Proteomic study pinpoints potential biomarkers for long-COVID diagnosis and persistent health impacts

A two-year longitudinal study highlights proteomic changes in long-COVID patients, revealing potential biomarkers for diagnosis and shedding light on the persistent physiological challenges faced by survivors.

Forta Secures $55M for AI-Driven ABA Therapy Expansion and LLM Research

What You Should Know: Forta, an AI healthcare company improving access to dependable quality care, today announced it has raised $55 million in Series A financing

January 17, 2024

Prenatal exposure to EDCs linked to accelerated BMI gain in children

A new study led by researchers from the Barcelona Institute for Global Health (ISGlobal), a center supported by the “la Caixa Foundation” has shed light

October 18, 2023

Evolus: Chiseling Away At The Aesthetic Market

Evolus is a facial beauty company that specializes in aesthetic neurotoxins, with its flagship product being Jeuveau. The company is expanding its product portfolio by

May 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.